<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01222871</url>
  </required_header>
  <id_info>
    <org_study_id>00540</org_study_id>
    <nct_id>NCT01222871</nct_id>
  </id_info>
  <brief_title>Treatment of Early Nasal Polyposis With Topical Triamcinolone</brief_title>
  <official_title>Treatment of Early Nasal Polyposis With Topical Triamcinolone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Steward St. Elizabeth's Medical Center of Boston, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Steward St. Elizabeth's Medical Center of Boston, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effectiveness of intranasal Triamcinolone
      delivered through a bio-absorbable nasal dressing verses oral steroids and a saline soaked
      dressing, in the treatment and prevention of early nasal polyposis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      nasopore, a bio-absorbable nasal dressing, may offer an alternative route of sustained
      steroid drug delivery. The use of topical targeted intranasal steroids may prevent the
      routine adverse effects of oral steroids while maintaining the same therapeutic / clinical
      efficacy.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    not enough particpants
  </why_stopped>
  <start_date type="Actual">July 2010</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients will be randomized into 2 study groups, experimental and control.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nasal Endoscopic Exam Findings .</measure>
    <time_frame>2 weeks, 6 weeks, 12 weeks were not collected from any participant.</time_frame>
    <description>nasal endoscopic exam findings at 2 weeks, 6 weeks and 12 weeks were not collected from any participant.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Nasal Polyps</condition>
  <arm_group>
    <arm_group_label>Triamcinolone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Triamcinolone soaked nasopore dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline soaked sponge</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone</intervention_name>
    <description>Triamcinolone soaked nasopore dressing</description>
    <arm_group_label>Triamcinolone</arm_group_label>
    <other_name>Kenalog (40)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline soaked sponge</intervention_name>
    <description>saline soaked sponge</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Patients with early nasal polyposis

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Patients with active sinus infections

          -  Patients on long term steroids

          -  Allergy or sensitivity to steroids

          -  Patients with Antrochoanal polyps

          -  Patients who received topical steroids by bio-resorbable sponge or oral steroids
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Catalano, MD</last_name>
    <role>Study Director</role>
    <affiliation>Steward St. Elizabeth's Medical Center of Boston, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Elizabeth's Medical Center, 736 Cambridge St</name>
      <address>
        <city>Brighton</city>
        <state>Massachusetts</state>
        <zip>02135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>October 14, 2010</study_first_submitted>
  <study_first_submitted_qc>October 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2010</study_first_posted>
  <results_first_submitted>December 12, 2014</results_first_submitted>
  <results_first_submitted_qc>June 27, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">June 28, 2018</results_first_posted>
  <last_update_submitted>June 27, 2018</last_update_submitted>
  <last_update_submitted_qc>June 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Steward St. Elizabeth's Medical Center of Boston, Inc.</investigator_affiliation>
    <investigator_full_name>Peter Catalano</investigator_full_name>
    <investigator_title>Chief of Otolaryngology</investigator_title>
  </responsible_party>
  <keyword>Treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nasal Polyps</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>One subject enrolled but study was terminated and subject did not start the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Triamcinolone</title>
          <description>Nasopore Triamcinolone soaked sponge</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Saline soaked sponge</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>0</population>
      <group_list>
        <group group_id="B1">
          <title>Triamcinolone</title>
          <description>Nasopore Triamcinolone soaked sponge</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Saline Soaked sponge</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="0"/>
            <count group_id="B2" value="0"/>
            <count group_id="B3" value="0"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>No participant started because study was terminated.</description>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <description>No participant started because study was terminated.</description>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                </category>
                <category>
                  <title>Male</title>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Nasal Endoscopic Exam Findings .</title>
        <description>nasal endoscopic exam findings at 2 weeks, 6 weeks and 12 weeks were not collected from any participant.</description>
        <time_frame>2 weeks, 6 weeks, 12 weeks were not collected from any participant.</time_frame>
        <population>No participant started because study was terminated.</population>
        <group_list>
          <group group_id="O1">
            <title>Triamcinolone</title>
            <description>Nasopore Triamcinolone soaked sponge</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Saline soaked sponge</description>
          </group>
        </group_list>
        <measure>
          <title>Nasal Endoscopic Exam Findings .</title>
          <description>nasal endoscopic exam findings at 2 weeks, 6 weeks and 12 weeks were not collected from any participant.</description>
          <population>No participant started because study was terminated.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>no data collected, Study terminated.</time_frame>
      <desc>No data collected, study terminated.</desc>
      <group_list>
        <group group_id="E1">
          <title>Triamcinolone</title>
          <description>Nasopore Triamcinolone soaked sponge</description>
        </group>
        <group group_id="E2">
          <title>Saline Soaked Sponge</title>
          <description>Nasopore saline soaked sponge</description>
        </group>
        <group group_id="E3">
          <title>Control</title>
          <description>Saline soaked sponge</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Peter catalano</name_or_title>
      <organization>SEMC</organization>
      <phone>1-617-789-5004</phone>
      <email>peter.catalano@steward.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

